Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIVEC HR: Chemo-hyperthermia with intravesical mitomycin vs BCG in high-risk NMIBC
2016-001186-85Phase 4Active
- Sponsor
- Dr. Felipe Villacampa
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mitomycin c in bladder cancer (2 arms), sponsored by Dr. Felipe Villacampa. Primary endpoint: Disease-free survival at 24 months. Started Jun 2016; status: active.
02
Drugs
mitomycin c
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2016-001186-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001186-85.